Skip to main content
Clinical Trials/EUCTR2004-001633-42-GB
EUCTR2004-001633-42-GBActive, not recruitingNot Applicable

Is there a role for Helicobacter pylori eradication in the treatment of laryngopharyngeal reflux? : A double blinded randomised case controlled clinical trial - H.pylori erradication in laryngopharyngeal rteflux.

HS GRAMPIA0 sites50 target enrollmentStarted: February 15, 2005Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • LARYNGOPHARYNGEAL REFLUX AS PROVEN ON HISTORY AND FULL EXAMINATION
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1- UPPER AERODIGESTIVE TRACT MALIGNANCY
  • 2- OTHER LARYNGEAL PATHOLOGY
  • 3- PATIENTS CURRENTLY ON PROTON PUMP INHIBITOR THERAPY
  • 4 - PATIENTS INVOLVED IN ANY OTHER CLINICAL TRIAL

Investigators

Sponsor
HS GRAMPIA

Similar Trials

Is there a role for Helicobacter pylori... | Clinical Trial